WP10

Intravital 3D bioprinting of coronary artery bypass.

Three-dimensional (3D) bioprinting represents an emerging tissue engineering strategy, that associates manufacturing-based biotechnology to biology for the development of functional bio-structures. The ultimate goal of bioprinting is the generation of de novo synthesized tissues/organs that are suitable for the tretment of degenerated, damaged or lost tissue/organs in patients. The goal of our multidisciplinary research team is to develop novel strategy for the treatment of cardiovascular conditions by combining 3D bio-printing strategies with emerging biomaterial and technology.

 
 

TEAM

Nicola Elvassore.png

N Elvassore

Principal investigator and coordinator of the research group.

Anna Urciuolo.jpg

A. Urciuolo

PhD in Bioscience, Master Degree in Medical Biotechnologies.
Development and application of 3D bioprinting strategies.

Cecilia Laterza.jpg

C Laterza

PhD in Experimental Neurology, Master Degree in Medical Biotechnologies 
Application and refinement of 3D bioprinting strategies.

Onelia Gagliano.jpg

O. Gagliano

PhD in Chemical Engineering, Master degree in Bioengineering
Development of computer-aided design (CAD) software and system automatization.

Paolo Raffa.jpeg

P. Raffa

PhD in Molecular Medicine, Master Degree in Medical Biotechnologies
Application of developed 3D bioprinting strategies.

Luca Brandolino.jpeg

L. Brandolino

Master Degree in Medical Biotechnologies.
Fellow granted by LIFELAB. Development of 3D bioprinting strategies and refinement of experimental procedures.